The pharmacokinetics and pharmacodynamics of eculizumab in patients with paroxysmal nocturnal hemoglobinuria.
Completed
- Conditions
- PNHrare blood disease10018849
- Registration Number
- NL-OMON48010
- Lead Sponsor
- Radboud Universitair Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 27
Inclusion Criteria
The patient has a diagnosis of PNH
The patient is treated with eculizumab
Willing to give informed consent
Exclusion Criteria
Not applicable
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Clearance and volume of distribution </p><br>
- Secondary Outcome Measures
Name Time Method <p>-</p><br>